Cite

Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study.

MLA

Yerushalmi, Gil M., et al. “Vaginal Mifepristone for the Treatment of Symptomatic Uterine Leiomyomata: An Open-Label Study.” Fertility and Sterility, vol. 101, no. 2, Feb. 2014, pp. 496–500. EBSCOhost, https://doi.org/10.1016/j.fertnstert.2013.10.015.



APA

Yerushalmi, G. M., Gilboa, Y., Jakobson-Setton, A., Tadir, Y., Goldchmit, C., Katz, D., & Seidman, D. S. (2014). Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study. Fertility and Sterility, 101(2), 496–500. https://doi.org/10.1016/j.fertnstert.2013.10.015



Chicago

Yerushalmi, Gil M, Yinon Gilboa, Ariella Jakobson-Setton, Yona Tadir, Chen Goldchmit, Danny Katz, and Daniel S Seidman. 2014. “Vaginal Mifepristone for the Treatment of Symptomatic Uterine Leiomyomata: An Open-Label Study.” Fertility and Sterility 101 (2): 496–500. doi:10.1016/j.fertnstert.2013.10.015.